| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |